https://orcid.org/0000-0002-9995-5522
References
- Rokkas T, Graham DY. How widespread and convenient H. pylori susceptibility testing will result in pharmacological opportunities. Expert Rev Gastroenterol Hepatol. 2023;17(1):1–7.
- Tang X, Shen Y, Hu R, et al. Re-assessment of the disk diffusion technique for routine antimicrobial susceptibility testing for Helicobacter pylori. Helicobacter. 2020;25(4):e12703.
- Xiong LJ, Tong Y, Wang Z, et al. Detection of clarithromycin-resistant Helicobacter pylori by stool PCR in children: a comprehensive review of literature. Helicobacter. 2013;18(2):89–101.
- Redondo JJ, Keller PM, Zbinden R, et al. A novel RT-PCR for the detection of Helicobacter pylori and identification of clarithromycin resistance mediated by mutations in the 23S rRNA gene. Diagn Microbiol Infect Dis. 2018;90(1):1–6.
- Kato S, Konno M, Maisawa S, et al. Results of triple eradication therapy in Japanese children: a retrospective multicenter study. J Gastroenterol. 2004;39(9):838–843.
- Kakiuchi T, Hashiguchi K, Imamura I, et al. Assessment of a novel method to detect clarithromycin-resistant Helicobacter pylori using a stool antigen test reagent. BMC Gastroenterol. 2020;20(1):397.
- Kakiuchi T, Okuda M, Matsuo M, et al. Smart Gene™ as an effective non-invasive point-of-care test to detect Helicobacter pylori clarithromycin-resistant mutation. J Gastroenterol Hepatol. 2022;37(9):1719–1725.